Buscar
Mostrando ítems 51-60 de 8846
Curcumin and paclitaxel induce cell death in breast cancer cell lines
(2018)
Breast cancer is one of the major health issues confronting women; however, treatment with conventional chemotherapeutic drugs is limited. Currently, paclitaxel is used as a therapeutic clinical agent to treat breast cancer ...
Histamine H4 receptor : insights into a potential therapeutic target in breast cancer
(2015)
Abstract: Breast cancer is the second most common cancer worldwide, and the leading cause of cancer
death in women. Several studies underlined the critical role of histamine in breast cancer development and
progression. ...
Molecular aspects of breast cancer resistance to drugs (Review)
(Spandidos Publ, 2015)
Despite continuous advances in the knowledge of breast cancer pathophysiology, this type of
neoplasia remains a leading cause of cancer-related death in women worldwide.
Carcinogenesis takes a progressive course from ...
From chromosomal abnormalities to the identification of target genes in mouse models of breast cancer
(Elsevier Inc, 2014-06-25)
Cytogenetic studies of breast cancer cells have identified numerous chromosomal imbalances, including gains in human chromosome regions 1q, 4p, 8q, and 20q and losses in regions 1p, 3p, 6q, 11q, 16q, 17p, and 22q. Mouse ...
Biomarkers in breast cancer
(2006)
Familial Breast Cancer in Costa Rica: An Initial Approach
(Universidad de Costa Rica, 2004)
Molecular Subtypes Of Breast Cancer Are Not Associated With The Clinical Under- Or Overstaging Of Breast CancerSubtipos Moleculares De Câncer De Mama Não Estão Associados Ao Subestadiamento Ou Ao Superestadiamento Do Câncer De Mama
(Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2016)